Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- DOI
- 10.1016/s0140-6736(13)62106-6
- Published
- 2014-02
- Container
- The Lancet
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-13-62106-6,
title = {Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial},
author = {Jeffrey Cummings and Stuart Isaacson and Roger Mills and Hilde Williams and Kathy Chi-Burris and Anne Corbett and Rohit Dhall and Clive Ballard},
year = {2014},
journal = {The Lancet},
doi = {10.1016/s0140-6736(13)62106-6},
url = {https://doi.org/10.1016/s0140-6736(13)62106-6}
}RIS
TY - JOUR TI - Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial AU - Jeffrey Cummings AU - Stuart Isaacson AU - Roger Mills AU - Hilde Williams AU - Kathy Chi-Burris AU - Anne Corbett AU - Rohit Dhall AU - Clive Ballard PY - 2014 JO - The Lancet DO - 10.1016/s0140-6736(13)62106-6 UR - https://doi.org/10.1016/s0140-6736(13)62106-6 ER -
APA
Cummings, J., Isaacson, S., Mills, R., Williams, H., Chi-Burris, K., Corbett, A., Dhall, R., & Ballard, C. (2014). Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(13)62106-6
Source records
- crossref · retrieved 2026-09-27T00:01:54.705Z